LUX-lung 3: A randomized, open-label, phase III study of...

Lung Cancer 2012 / 6 Vol. 77

LUX-lung 3: A randomized, open-label, phase III study of afatinib vs pemetrexed and cisplatin as first-line treatment for patients with advanced adenocarcinoma of the lung harboring EGFR-activating mutations

Schuler, Martin, Yang, James Chih-Hsin, Yamamoto, Nobuyuki, O’Byrne, Ken, Hirsh, Vera, Mok, Tony, Massey, Dan, Zazulina, Victoria, Shahidi, Mehdi, Sequist, Lecia
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
77
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2012.05.043
Date:
June, 2012
File:
PDF, 53 KB
english, 2012
Conversion to is in progress
Conversion to is failed